Seminars in Arthritis and Rheumatism

Papers
(The H4-Index of Seminars in Arthritis and Rheumatism is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Gout epidemiology and comorbidities155
Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease115
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs114
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis93
C-reactive protein and implications in rheumatoid arthritis and associated comorbidities92
The biology of urate81
The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic review81
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review79
Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies69
Understanding differences between men and women with axial spondyloarthritis64
Articular cartilage regeneration: The role of endogenous mesenchymal stem/progenitor cell recruitment and migration60
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States57
Therapeutic approaches in the treatment of gout56
Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 202054
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients49
What we already know about the effects of exercise in patients with fibromyalgia: An umbrella review47
Axial involvement in psoriatic arthritis: An update for rheumatologists47
Antisynthetase syndrome – much more than just a myopathy45
Addressing the rheumatology workforce shortage: A multifaceted approach45
COVID-19 in rheumatic disease patients on immunosuppressive agents45
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review44
Is there a bidirectional association between rheumatoid arthritis and periodontitis? A systematic review and meta-analysis44
Nonsteroidal anti-inflammatory drugs and cardiovascular risk – a matter of indication41
The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems41
Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?39
Endemic Kashin–Beck disease: A food-sourced osteoarthropathy38
Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis38
Biomarkers in IgG4-related disease: A systematic review37
Effectiveness of tocilizumab in Behcet's disease: A systematic literature review37
Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis36
Sexual function and reproduction can be impaired in men with rheumatic diseases: A systematic review36
Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa35
Advances in our understanding of gout as an auto-inflammatory disease34
The ASAS-OMERACT core domain set for axial spondyloarthritis34
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study34
0.035993099212646